# Contact PrescribedReta — Retatrutide Research Digest

> Contact PrescribedReta — an independent editorial publisher summarizing peer-reviewed retatrutide research. For factual corrections, source questions, or editorial feedback.

For factual corrections, citation questions, or editorial feedback.

## Get in touch

PrescribedReta is an independent editorial publisher. We welcome factual corrections and source questions. If you believe a citation is wrong, a figure is misrepresented, or a published finding has been mischaracterized, we want to know.

We are not a clinic, a pharmacy, or a telehealth provider. We cannot answer medical questions, provide dosing guidance, or recommend treatment. For retatrutide clinical trial inquiries, Eli Lilly's clinical trials website and ClinicalTrials.gov (https://clinicaltrials.gov) are the appropriate resources.

Use the form below to reach the editorial team.

## Editorial scope

This site covers published peer-reviewed research and registered clinical trials on retatrutide. We do not cover:

- Medical or clinical advice of any kind
- Product availability, sourcing, or purchasing
- Dosing recommendations for personal use
- Comparisons with regulated prescription medications in an advisory context

Corrections or updates backed by a published primary source are the most useful feedback we receive.

---

A blueprint-level reading of the published retatrutide trial record — Phase 2 figures logged to source, the kidney and cardiac questions marked open, and no clinic, prescription, or product behind the drafting sheet.